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Contrast-Enhanced Magnetic Resonance
Angiography: Dose the Test Dose Bolus
Represent the Main Dose Bolus Accurately?
Objective: To determine whether the time-intensity curves acquired by test
and main dose contrast injections for MR angiography are similar. 
Materials and Methods: In 11 patients, repeated contrast-enhanced 2D-turbo-
FLASH scans with 1-sec interval were obtained. Both test and main dose time-
intensity curves were acquired from the abdominal aorta, and the parameters of
time-intensity curves for the test and main boluses were compared. The parame-
ters used were arterial and venous enhancement times, arterial peak enhance-
ment time, arteriovenous circulation time, enhancement duration and enhance-
ment expansion ratio. 
Results: Between the main and test boluses, arterial and venous enhance-
ment times and arteriovenous circulation time showed statistically significant cor-
relation (p < 0.01), with correlation coefficients of 0.95, 0.92 and 0.98 respective-
ly. Although the enhancement duration was definitely greater than infusion time,
reasonable measurement of the end enhancement point in the main bolus was
impossible. 
Conclusion: Only arterial and venous enhancement times and arteriovenous
circulation time of the main bolus could be predicted from the test-bolus results.
The use of these reliable parameters would lead to improvements in the scan tim-
ing method for MR angiography.
he development of higher performance gradients, which can acquire
three-dimensional images within 40 seconds, has led to improvements in
contrast-enhanced MR angiography procedures, and the technique has
become acceptable as a feasible diagnostic modality (1 7). To maximize arterial signal
intensity, bolus injection of contrast media using a power injector was introduced and
the subsequent adoption of this injection technique represents a useful procedural im-
provement (8, 9). The bolus enhancement thus obtained resulted, however, in a nar-
row temporal window for data acquisition and high levels of venous and soft tissue en-
hancement. To overcome these problems, large amounts of contrast medium and pre-
cise acquisition timing have been emphasized (1, 8, 10 13). 
For proper acquisition timing, data acquisition was usually delayed after bolus injec-
tion of the contrast media until peak enhancement of the target vessel. Several meth-
ods for calculating scan delay time have been suggested (1, 6, 8, 10), and among these,
the method suggested by Prince (1) (scan delay time = peak enhancement time + infu-
sion time/2  acquisition time/2), has been commonly used. Time-intensity curves for
the test-bolus injection of contrast media are plotted, and the peak enhancement time
of the target vessel is thus predicted. Filling the center of K-space during peak en-
hancement of the main contrast bolus is thought to be the best method of increasing
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Tprecision (1, 8). To compensate for the discrepancy in peak
enhancement times between the test and main bolus, con-
stants or variables were therefore added to the peak en-
hancement time of the test bolus. The variable used was in-
variably  half of the infusion time . This compensation was
based on the premise that the length of the main contrast
bolus would be equal to the infusion time of the main bo-
lus. 
We found, however, that enhancement duration and in-
fusion time during routine MR angiography were different.
A previous study also demonstrated that a 0.5-sec test in-
jection of 1 mL gadolinium chelate led to 6 8 secs of arte-
rial enhancement (8). This inequality between infusion
time and enhancement duration results in calculation of a
shorter scan delay time and earlier data acquisition. This
latter includes a large portion of the unenhanced phase, es-
pecially in the case of MR angiography using a low-dose
contrast medium coupled with rapid injection.
In this study, we aimed to establish the most reliable pa-
rameters for determining scan delay time in MR angiogra-
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Fig. 1. Arterial (solid line) and venous (dotted line) time-intensity curves acquired from a 66-year-old female. 
A. For the test-bolus study, 2 ml of contrast medium was injected at a rate of 3 ml / sec. Tae, Tp, Tve, and ED were 13, 18, 35, and 17
seconds, respectively. The calculated values of Tav and EER obtained from the above data were 22 sec and 25.76.
B. For the main-bolus study, 12 ml of contrast medium was injected at a rate of 3 ml / sec. Tae, Tp, and Tve were 14, 25, and 36 sec-
onds, respectively, and Tav was 22 sec. ED could not be measured on this graph due to the uncertain end-point of enhancement. It is
certain, however, that the duration of arterial enhancement was markedly greater (4 secs) than that of the infusion of contrast media. Tae
= Arterial enhancement time, Tp = Arterial peak enhancement time, Tve = Venous enhancement time, ED = Enhancement duration, Tav
= Arteriovenous circulation time, EER = Enhancement expansion ratiophy, and to this end compared the time-intensity curves
obtained from test and main bolus injections. 
MATERIALS AND METHODS
Subjects
Eleven volunteers were involved in this experiment and
for the evaluation of musculoskeletal pathology, all under-
went MR imaging procedures. The sex ratio was 7:4 (male:
female) and their ages ranged from 15 to 68 (mean, 40.4)
years. All experiments were carried out with institutional
review board approval and the subjects informed consent.
During musculoskeletal MR examination, the step involv-
ing contrast-enhancement was replaced by this experiment.
Just before the acquisition of contrast-enhanced muscu-
loskeletal MR images, test-bolus and main bolus studies
were performed consecutively. Because no arterial en-
hancement phase was needed during this imaging proce-
dure, our experiment did not lead to the deterioration of
musculoskeletal MR images. 
Examination protocol
For the test-bolus study, 2 mL of contrast media
(Omniscan, Nycomed Imaging AS, Oslo, Norway) was in-
jected into the right antecubital vein of the upper extremi-
ty through a 20 21 gauge needle at a rate of 3 ml / sec,
using a power injector (Medrad, Indianola, PA). In order to
propel the previously injected contrast bolus, 20 ml of nor-
mal saline was subsequently injected behind the contrast
medium at the same rate. Repeated acquisition of image
data coincided with the start of contrast injection, and im-
ages were acquired for a period of 120 seconds. A 1.5T
MRI scanner (Magnetom Vision Plus; Siemens Medical sys-
tems, Erlangen, Germany) was used with the pulse se-
quence set at two-dimensional turbo fast low angle shot
(turbo-FLASH). Repetition time (TR), echo time (TE), and
flip angle (FA) were 8.5 msec, 4.0 msec, and 10 degrees,
respectively. The inversion time of this sequence was 100
ms and sinc interpolation was performed. Slice thickness,
field of view (FOV), numbers of phase encoding (Ny) and
frequency encoding (Nz) were 8 mm, 263 350 mm, 96
and 256, respectively. The receiver bandwidth was 355
Hz/pixel and data oversampling was set along the read-out
gradient. A saturation band was not added. Temporal reso-
lution was one second and acquisition continued for 120
seconds by means of two sequential 60-second scans, with-
out intermission. This repeated acquisition was performed in
a single slice at the level of the infrarenal abdominal aorta. 
The main-bolus study involved the use of the same pulse
sequence at the same location. The dose of injected con-
trast material was 0.1 mmol / kg and the injection rate was
the same as that of the test-bolus. Acquisition continued
for 180 seconds in three consecutive phases, during which
time the subjects breathed normally.
Data analysis
After the reconstruction of raw data, time-intensity
curves for each phase of each part of the study were drawn
corresponding to the aorta and the inferior vena cava. In
order to cover the whole cross sectional area of the aorta
and the inferior vena cava, regions of interest (ROI s) were
drawn as large as possible. To reduce inter-observer error
between the test-bolus and main bolus studies, all ROI s
were drawn by a single researcher. Automatic scaling was
selected for each time-intensity curve obtained during the
first phase. For the time-intensity curves of the second and
third phases, maximum signal intensity was manually
equalized to that of the first phase curve in order to pro-
vide a normalized series of curves across the three phases. 
The parameters measured from the time-intensity curves
were arterial and venous enhancement time (Tae and Tve),
arteriovenous circulation time (Tav), arterial peak- en-
hancement time (Tp), enhancement duration (ED) and en-
hancement expansion ratio (EER) (Fig. 1). Enhancement
time was defined as the time interval between the starting
point of data acquisition and the point at which half-maxi-
mum height in the upstroke portion of the time-intensity
curve was seen, and from it, the arrival time of the contrast
bolus at the target vessel could be inferred. The formula for
the arteriovenous circulation time (Tav) was as follows: -
Tav  =  Tve  Tae [1] 
where Tav is the period of pure arterial enhancement be-
fore subsequent venous enhancement. Tp is the time taken
to reach the peak of the arterial time-intensity curve and
represents the time for peak enhancement. This parameter
was the only one used in traditional scan delay time calcu-
lations. ED was defined as the time interval between the
rising point of the arterial time-intensity curve and the end
point of the downstroke of the curve as it approached the
baseline of residual enhancement. In traditional timing
methods, this parameter is regarded as equal to infusion
time; thus, instead of ED, infusion time was used as a vari-
able to fit the center of the main bolus to the center of data
acquisition time. Since ED was presumed to be longer than
infusion time, EER was also measured, and was calculated
according to the following formula: -
EER =   [2]
where Ti = infusion time of contrast media (sec)
ED 
Ti
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as short an intermission as possible. Test bolus and main
bolus in a single volunteer were thus compared on the as-
sumption that both studies were performed while physio-
logical status was the same. Using Pearson s correlation,
parameters were analyzed and compared.
RESULTS
Average Tae s in the test-bolus and main bolus studies
were 12.73 and 13.00 seconds, respectively. When the
main bolus time-intensity curve was compared with that of
the test-bolus, Tae ratios ranged from 0.89 to 1.43 with an
average of 1.05, implying a slightly delayed Tae for the
main bolus. This latter showed a higher maximal signal in-
tensity at Tp than did the test bolus. Average Tav s of the
test-bolus and main bolus studies were 15.09 and 16.36
seconds, respectively. The average ratio of Tav ratio 1.10,
indicative of a slightly longer Tav for the main bolus. For
these two comparisons, the correlation coefficients of 0.95
(p < 0.01) and 0.92 (p < 0.01), respectively, were statisti-
cally significant. The correlation coefficient of Tve s be-
tween test and main boluses was 0.98 (p < 0.01) (Tables 1
and 2).
The ED s of both main and test bolus were increased
more than did infusion times. Since no acute translation
point was detected in the down-slope of the time-intensity
curve, the ED of the main bolus was hard to define accu-
rately. The EER of the test-bolus study showed a wide
range, from 16.00 to 67.16 (average, 25.43) depending on
the subject. The Tp of the main bolus was 1.7 times longer
than that of the test bolus. The comparisons of ED, EER
and Tp showed no statistically significant correlations with
high standard deviations (Tables 1 and 2, Fig. 2), though it
was clear that Tp in the test-bolus study matched the initial
portion of the main bolus. The matched portion ranged
from 0 to 13.33 (average, 5.4) percentile of the main bolus
(Fig. 2). 
DISCUSSION
The most accepted traditional method for calculation of
the scan delay time (1) fits the center of data acquisition to
a point consisting of the arterial peak enhancement time of
the test-bolus and half of the injection duration, with the
purpose of matching the centers of K-space and the main
bolus. As seen in the results of this study, however, the ar-
terial peak enhancement time acquired from the test-bolus
study matched the initial portion (less than the 13th per-
centile) of the main bolus rather than its center. In addi-
tion, the mismatch between arterial peak enhancement
time and the center of the main bolus was not compensat-
ed for by adding one half of the injection duration, since
the bolus tends to elongate more than the duration of in-
jection. In fact, the traditional method places the center of
data acquisition at the initial portion of the main bolus,
making the initial portion of K-space acquire the unen-
hanced and less enhanced arterial signal. Infusion time and
arterial enhancement time, the parameters for determining
scan delay time by the traditional method, therefore
showed poor statistical correlation between test and main
boluses.
On the basis of the results of this study, we are able to
suggest the most reliable parameters for determining the
scan delay time in MR angiography. From the time-intensi-
ty curves obtained from the test and main bolus injections,
we found that arterial and venous enhancement times and
arteriovenous circulation time obtained from the test bolus
showed statistically significant correlation between the test
and main boluses. That is, these three parameters predicted
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Table 1. Comparison of the Parameters of Time-intensity
Curves Acquired by Main and Test-bolus Studies
Parameter Test bolus study Main bolus study
Average Standard  Average Standard 
Deviation Deviation
Ti (sec) 0.66 0.00 4.09 0.86
Tae (sec) 12.73 3.95 13.00 3.32
Tve (sec) 27.82 7.90 29.36 7.75
ED (sec) 18.09 9.62
Tp (sec) 16.27 4.71 26.00 7.32
Tav (sec) 15.09 5.47 16.36 5.43
EER (times) 25.43 14.86
Note. Ti = Infusion time, Tae = Arterial enhancement time, Tve =
Venous enhancement time, ED = Enhancement duration, Tp = Peak
enhancement time, Tav = Arteriovenous circulation time, EER =
Enhancement expansion ratio,  = Not measurable
Table 2. Parameters Expressed as Ratio of Main Bolus to
Test-Bolus
Ratio (Main/Test) (Times) Correlation 
Average Standard Deviation Coefficient
Tae 1.05 0.14 0.95
Tve 1.06 0.06 0.98
Tp 1.66 0.48 0.55 
Tav 1.10 0.15 0.92
EER
Note. Tae = Arterial enhancement time, Tve = Venous enhancement
time, Tp = Arterial peak enhancement time, Tav = Arteriovenous
circulation time, EER = Enhancement expansion ratio,  = Not
measurable,  = p < 0.01 in Pearson Correlation Analysisthe shape of main bolus. 
In this study, standardization of the parameters was
achieved by selecting approximate median values of adja-
cent plots on the time-intensity curve, which was affected
by pulsating arterial flow (Fig. 2). Arterial and venous en-
hancement times were defined as the times showing half-
maximum intensities. Arteriovenous circulation time was
subsequently defined as the gap between arterial and ve-
nous enhancement times, and might represent pure arterial
enhancement without venous contamination. It was also
noted that the circulation time of the main bolus showed a
slight delay (a factor of 1.10 on average) compared to the
test-bolus. In the main bolus, due to increased venous peak
signal intensity, the time of half-maximum intensity (ve-
nous enhancement time) was delayed, leading to increased
arteriovenous circulation time (Fig. 2). Arterial enhance-
ment time of the main bolus was also slightly delayed (a
factor of 1.05, on average) compared with that of the test
bolus. Although the causes of slight delays in arteriovenous
circulation time and arterial enhancement time are not
clearly understood these parameters showed close statisti-
cal correlation between test and main boluses. To elucidate
the causes and the implications of these delays, a more
comprehensive study is required.
With regard to enhancement duration, which might play
a role in determining scan delay time, the test-bolus time-
intensity curve showed a definite rising point and a point at
which it reached a post-enhancement plateau, so there was
no difficulty in measuring bolus length. For the test bolus,
the duration of enhancement was definitely greater than
the infusion time of the contrast medium. On the main bo-
lus time-intensity curve, the point at which the post-en-
Contrast-Enhanced Magnetic Resonance Angiography
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Fig. 2. Each parameter of the main and test-bolus studies.
A. Arterial enhancement times of both studies show excellent cor-
relation. 
B. Arteriovenous circulation times also show good correlation be-
tween both studies. 
C. Plots of arterial peak enhancement time shifted toward the Y-ax-
is, implying a definite delay in the main-bolus study as compared
with the test-bolus study. Both studies also show widely spread da-
ta, with poor correlation.hancement plateau was reached could not be clearly de-
fined; this was because the elevated curve did not show a
sharp deviation towards the plateau. Measurement of the
duration of enhancement thus had an associated high level
of uncertainty. It was clear, however, that for the main bo-
lus, arterial enhancement time was much longer than infu-
sion time. To investigate the correlation between enhance-
ment duration and infusion time we calculated the en-
hancement expansion ratio defining this as enhancement
duration divided by infusion time. There was, however, no
significant correlation between this ratio and infusion time
of the test bolus. Since, in the case of the main bolus, accu-
rate measurement was not available, a comparison of the
enhancement expansion ratio between the test and main
bolus was not possible. These findings suggest that the en-
hancement expansion ratio can not be used as a parameter
for predicting the characteristics of the main bolus. 
Other considerations in this study were the effect of
saline flush and the amount and injection rate of the test
bolus. During the injection of contrast media, saline flush-
ing was routinely added in CE-MRA, though the effect of
this was not clearly confirmed. Our experience suggests
that if a contrast bolus is followed by a saline bolus, the
former will be pushed, and a higher flow rate than that of
normal venous blood thus achieved. The contrast bolus is
thus able to reach the right atrium with less dilution by un-
enhanced blood from conjoining venous branches. In the
test-bolus study, 2 ml of contrast media was injected at a
rate of 3 mL/sec. Although some reports have suggested
that 1 ml of contrast bolus should be sufficient for a time-
intensity curve (6, 8, 14), a 2 mL test bolus was used in or-
der to achieve improved definition of the venous time-in-
tensity curve. As for the injection rate, no published re-
port, as far as we know, has suggested an optimal injection
rate for the three-dimensional turbo-FLASH sequence. It
has, however, been reported that an adequate injection
rate for evaluating the abdominal aorta in a three-dimen-
sional FISP sequence is 2 mL/sec (15). In this study, be-
cause venous enhancement was known to be related to in-
jection rate (6, 9, 14), the injection rate of contrast media
for the augmentation of venous enhancement was set to a
relatively high value, namely 3 mL/sec. 
Finally, the effect of respiratory motion and pulsating
blood flow on the time-intensity curves requires comment.
At the level of image acquisition, the aorta and inferior ve-
na cava were located at the center of a radially redundant
respiratory motion. The ROIs were not shifted over the
boundaries of target vessels in all serially acquired images,
and free breathing was therefore allowed during acquisi-
tion. Periodic signal changes occurred in the aorta due to
pulsating blood flow, however, and the resultant fluctua-
tions were noted in the time-intensity curves. According to
recent reports (6, 14), the addition of presaturation slabs at
the superior and inferior aspects of the acquisition area is
an effective way of reducing such flow-related signal
changes in arteries and veins. 
As a result of this study, we can confirm two facts.
Firstly, the contrast bolus in the systemic artery was exten-
sively and variably elongated, compared with infusion
time. This latter, which is commonly used for scan-timing
calculations, thus appears to be an inappropriate variable
to substitute for the length of the main bolus. Secondly,
among the parameters examined, the arterial and venous
enhancement times and the arteriovenous circulation time
of the test bolus were consistent with the characteristics of
the main bolus. Other parameters such as peak enhance-
ment time, enhancement duration and enhancement ex-
pansion ratio showed no statistical consistency between
test and main boluses. In conclusion, the application of reli-
able parameters to the determination of scan delay time by
means of MR angiography is likely to provide higher quali-
ty images. 
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